Funds · ALLO

Who owns ALLO?

Institutional ownership of Allogene Therapeutics Inc. from Form 13F, Q2 2026

209 institutional managers reported holding Allogene Therapeutics Inc. (ALLO) in Form 13F filings for Q2 2026, with 312,662,114 shares worth $652M. The largest reported holder was BlackRock, Inc. Managers that filed both quarters added a net 128,660,152 shares (+69.9%). 33 opened new positions and 28 sold out.

Funds holding
209
Value held
$652M
New / sold out
33 / 28
Net shares, same filers
+69.9%

Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.

Largest holders of ALLO

FundValueShare of 13F holdingsSharesMove
BlackRock, Inc.$62.7M9.6%30,146,963Added
Pfizer Inc$46.9M7.0%22,032,040Unchanged
Frazier Life Sciences Management, L.P.$46.7M7.2%22,446,668Added
State Street Corp$39.6M6.1%19,025,826Added
TPG GP A, LLC$38.9M6.0%18,716,306Unchanged
Sio Capital Management, LLC$27.7M4.3%13,323,431New
Primecap Management Co$27.3M4.2%13,123,440Added
Vanguard Capital Management LLC$25.3M3.9%12,166,636Added
FMR LLC$25.0M3.8%12,009,043Added
Citadel Advisors LLC$21.0M3.2%10,087,770Added
Two Sigma Investments, LP$16.2M2.5%7,784,348Added
Geode Capital Management, LLC$14.7M2.3%7,049,328Added
Goldman Sachs Group Inc$12.8M2.0%6,148,959Added
GordonMD Global Investments LP$11.0M1.7%5,298,000Added
Marshall Wace, LLP$10.6M1.6%5,095,408Added
Patient Square Capital LP$10.5M1.6%5,050,000Added
Aberdeen Group plc$10.4M1.6%5,001,752Added
Millennium Management LLC$10.1M1.5%4,843,889Added
D. E. Shaw & Co., Inc.$9.8M1.5%4,710,735Added
Price T Rowe Associates Inc$9.7M1.5%4,639,283Trimmed
Morgan Stanley$9.4M1.4%4,509,962Added
Woodline Partners LP$9.4M1.4%4,500,624Added
Candriam S.C.A.$9.0M1.4%4,336,296Added
Vanguard Portfolio Management LLC$8.8M1.3%4,212,078Added
Renaissance Technologies LLC$8.0M1.2%3,834,312Added

Share of 13F holdings is each fund's shares as a share of the 312,662,114 ALLO shares all 13F filers reported, not of shares outstanding.

Biggest buyers in Q2 2026

  1. Frazier Life Sciences Management, L.P. Added+$38.8M
  2. Sio Capital Management, LLC New+$27.7M
  3. BlackRock, Inc. Added+$23.0M
  4. FMR LLC Added+$21.7M
  5. State Street Corp Added+$21.6M
  6. Vanguard Capital Management LLC Added+$10.9M
  7. Primecap Management Co Added+$9.9M
  8. GordonMD Global Investments LP Added+$8.0M
  9. HRT Financial LP Added+$7.5M
  10. Aberdeen Group plc Added+$7.4M

Biggest sellers in Q2 2026

  1. MPM Bioimpact LLC Sold out-$5.5M
  2. Nuveen, LLC Trimmed-$3.5M
  3. Balyasny Asset Management L.P. Sold out-$2.9M
  4. Boxer Capital Management, LLC Trimmed-$2.5M
  5. Price T Rowe Associates Inc Trimmed-$1.5M
  6. Jane Street Group, LLC Sold out-$1.2M
  7. Jacobs Levy Equity Management, Inc Trimmed-$1.2M
  8. AQR Capital Management LLC Trimmed-$995K
  9. Algert Global LLC Trimmed-$710K
  10. XTX Topco Ltd Trimmed-$592K

The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $292M and sold $25.8M; 99 added and 49 trimmed.

Schedule 13D and 13G filings on ALLO

Owners of more than 5% must file within days, so these can be newer than the 13F data.

Questions about ALLO ownership

Who owns ALLO stock?
209 institutional investment managers reported ALLO positions in their Form 13F filings for Q2 2026, holding 312,662,114 shares worth $652M in total. BlackRock, Inc. reported the largest position.
Are funds buying or selling ALLO?
In Q2 2026, 33 managers opened new ALLO positions, 99 added, 49 trimmed and 28 sold out. Managers that filed in both quarters added a net 128,660,152 shares.
How current is this ALLO institutional ownership data?
It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.

From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to ALLO by CUSIP. Options are left out. ALLO news and filings · ALLO insider trades · Top funds